middle.news
Nova Eye Medical turns positive EBITDA into a launchpad for further growth
12:59pm on Tuesday 27th of October, 2026 AEDT
•
Medical Technology
Read Story
Nova Eye Medical turns positive EBITDA into a launchpad for further growth
12:59pm on Tuesday 27th of October, 2026 AEDT
Key Points
US$6.3 million quarterly sales, up 30% year on year
US$25.1 million in trailing twelve-month sales
A$0.5 million operating cash inflow and positive quarterly EBITDA
A$4.1 million of cash and unused debt facility
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nova Eye Medical (ASX:EYE)
OPEN ARTICLE